Clinical Trials Browser

NIH × Depression × Temozolomide × Clear all

NCT01342757 2018-01-29

Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

Phase NA Completed

12 enrolled 8 charts

Brain Neoplasms, Depression, Glioblastoma